{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:49Z","timestamp":1791823729546,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) remains incurable and exhibits exceptionally high metabolic demands, driving the evolution of hyperactive mitochondrial systems within tumors. In parallel, mitochondrial transfer from astrocytes to cancer cells fuels metabolic reprogramming and enhances GBM tumorigenicity. These malignant traits markedly constrain therapeutic efficacy and patient survival. Herein, we report a dehydroascorbic acid (DHA)-functionalized, ROS-responsive, ferrocene-integrated polymer nanoplatform (GS@DFP) co-loaded with S-Gboxin and Galunisertib, simultaneously targeting GBM mitochondria and mitochondrial transfer in astrocyte-cancer cell crosstalk. After crossing the blood-brain barrier (BBB) through Glut1-mediated transport enabled by DHA, GS@DFP responds to elevated intracellular reactive oxygen species (ROS) levels in GBM to trigger payload release and initiate Fenton reactions. S-Gboxin inhibits mitochondrial complex V and depletes ATP, whereas Galunisertib downregulates TGF-\u03b2\/SMAD-driven thrombospondin-1 (TSP-1) expression, suppressing tumor microtube (MT) formation and thereby reducing astrocyte-to-GBM mitochondrial transfer. Notably, TGF-\u03b2 inhibition also reprograms the immunosuppressive tumor microenvironment (TME). This work establishes a multifunctional nanoplatform that targets mitochondrial vulnerabilities and intercellular crosstalk, offering a translatable strategy for enhancing GBM therapy.<\/jats:p>","DOI":"10.1038\/s41467-026-77395-2","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:35:01Z","timestamp":1789032901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ROS-autocatalytic nanoplatform interfering astrocyte-cancer crosstalk and enhancing glioblastoma therapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3999-5641","authenticated-orcid":false,"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-2725","authenticated-orcid":false,"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-1216","authenticated-orcid":false,"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"77395_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","volume":"10","author":"S Singh","year":"2025","unstructured":"Singh, S. et al. Glioblastoma at the crossroads: current understanding and future therapeutic horizons. Signal Transduct. Target. Ther. 10, 213 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"77395_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","volume":"10","author":"M Weller","year":"2024","unstructured":"Weller, M. et al. Glioma. Nat. Rev. Dis. Primers 10, 33 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"77395_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41586-025-09191-9","volume":"644","author":"BM Andersen","year":"2025","unstructured":"Andersen, B. M. et al. Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions. Nature 644, 1097\u20131106 (2025).","journal-title":"Nature"},{"key":"77395_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cell.2024.11.002","volume":"188","author":"SK Tetzlaff","year":"2025","unstructured":"Tetzlaff, S. K. et al. Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing. Cell 188, 390\u2013411 (2025).","journal-title":"Cell"},{"key":"77395_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41586-023-06036-1","volume":"617","author":"S Krishna","year":"2023","unstructured":"Krishna, S. et al. Glioblastoma remodelling of human neural circuits decreases survival. Nature 617, 599\u2013607 (2023).","journal-title":"Nature"},{"key":"77395_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41586-025-08997-x","volume":"643","author":"C Faust Akl","year":"2025","unstructured":"Faust Akl, C. et al. Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity. Nature 643, 219\u2013229 (2025).","journal-title":"Nature"},{"key":"77395_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s43018-023-00556-5","volume":"4","author":"DC Watson","year":"2023","unstructured":"Watson, D. C. et al. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat. Cancer 4, 648\u2013664 (2023).","journal-title":"Nat. Cancer"},{"key":"77395_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/neuonc\/noab212","volume":"24","author":"JV Joseph","year":"2022","unstructured":"Joseph, J. V. et al. TGF-\u03b2 promotes microtube formation in glioblastoma through thrombospondin 1. Neuro Oncol 24, 541\u2013553 (2022).","journal-title":"Neuro Oncol"},{"key":"77395_CR9","doi-asserted-by":"crossref","unstructured":"Storevik, S. et al. Mitochondria transfer in glioblastoma. Neuro Oncol 28, 1353\u20131365 (2026).","DOI":"10.1093\/neuonc\/noag038"},{"key":"77395_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41568-022-00475-0","volume":"22","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani, V. et al. Disconnecting multicellular networks in brain tumours. Nat. Rev. Cancer 22, 481\u2013491 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"77395_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40280-3","volume":"14","author":"Y Zou","year":"2023","unstructured":"Zou, Y. et al. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat. Commun. 14, 4557 (2023).","journal-title":"Nat. Commun."},{"key":"77395_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","volume":"567","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature 567, 341\u2013346 (2019).","journal-title":"Nature"},{"key":"77395_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/neuonc\/now009","volume":"18","author":"AA Brandes","year":"2016","unstructured":"Brandes, A. A. et al. A phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. Neuro Oncol 18, 1146\u20131156 (2016).","journal-title":"Neuro Oncol"},{"key":"77395_CR14","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/neuonc\/now112","volume":"18","author":"D Mangani","year":"2016","unstructured":"Mangani, D. et al. Limited role for transforming growth factor-\u03b2 pathway activation-mediated escape from VEGF inhibition in murine glioma models. Neuro Oncol 18, 1610\u20131621 (2016).","journal-title":"Neuro Oncol"},{"key":"77395_CR15","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","volume":"187","author":"JG Baldwin","year":"2024","unstructured":"Baldwin, J. G. et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell 187, 6614\u20136630 (2024).","journal-title":"Cell"},{"key":"77395_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha, T. et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat. Nanotechnol. 17, 98\u2013106 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"77395_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41586-024-07340-0","volume":"629","author":"RZ Lin","year":"2024","unstructured":"Lin, R. Z. et al. Mitochondrial transfer mediates endothelial cell engraftment through mitophagy. Nature 629, 660\u2013668 (2024).","journal-title":"Nature"},{"key":"77395_CR18","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s43018-025-01038-6","volume":"6","author":"M Cangkrama","year":"2025","unstructured":"Cangkrama, M. et al. MIRO2-mediated mitochondrial transfer from cancer cells induces cancer-associated fibroblast differentiation. Nat. Cancer 6, 1714\u20131733 (2025).","journal-title":"Nat. Cancer"},{"key":"77395_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","volume":"638","author":"H Ikeda","year":"2025","unstructured":"Ikeda, H. et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature 638, 225\u2013236 (2025).","journal-title":"Nature"},{"key":"77395_CR20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41556-023-01246-1","volume":"25","author":"S Tiash","year":"2023","unstructured":"Tiash, S., Brestoff, J. R. & Crewe, C. A guide to studying mitochondria transfer. Nat. Cell Biol. 25, 1551\u20131553 (2023).","journal-title":"Nat. Cell Biol."},{"key":"77395_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41586-025-09176-8","volume":"644","author":"G Hoover","year":"2025","unstructured":"Hoover, G. et al. Nerve-to-cancer transfer of mitochondria during cancer metastasis. Nature 644, 252\u2013262 (2025).","journal-title":"Nature"},{"key":"77395_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s42255-024-01200-x","volume":"7","author":"JR Brestoff","year":"2025","unstructured":"Brestoff, J. R. et al. Recommendations for mitochondria transfer and transplantation nomenclature and characterization. Nat. Metab. 7, 53\u201367 (2025).","journal-title":"Nat. Metab."},{"key":"77395_CR23","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41565-024-01769-0","volume":"19","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 19, 1869\u20131879 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"77395_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202100746","volume":"33","author":"P Liu","year":"2021","unstructured":"Liu, P. et al. Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer\u2019s disease by inflammatory microenvironment modulation. Adv. Mater. 33, e2100746 (2021).","journal-title":"Adv. Mater."},{"key":"77395_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201808361","volume":"31","author":"Y Lu","year":"2019","unstructured":"Lu, Y. et al. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Adv. Mater. 31, e1808361 (2019).","journal-title":"Adv. Mater."},{"key":"77395_CR26","doi-asserted-by":"publisher","first-page":"25257","DOI":"10.1021\/acsnano.3c08485","volume":"17","author":"J Luo","year":"2023","unstructured":"Luo, J. et al. Reversing ferroptosis resistance in breast cancer via tailored lipid and iron presentation. ACS Nano 17, 25257\u201325268 (2023).","journal-title":"ACS Nano"},{"key":"77395_CR27","doi-asserted-by":"publisher","first-page":"17755","DOI":"10.1021\/jacs.3c04454","volume":"145","author":"C Song","year":"2023","unstructured":"Song, C. et al. Self-amplified cascade degradation and oxidative stress via rational pH regulation of oxidation-responsive poly(ferrocene) aggregates. J. Am. Chem. Soc. 145, 17755\u201317766 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"77395_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202303829","volume":"62","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. Self-immolative amphiphilic poly(ferrocenes) for synergistic amplification of oxidative stress in tumor therapy. Angew. Chem. Int. Ed. 62, e202303829 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"77395_CR29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.apsb.2022.09.019","volume":"13","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy. Acta Pharm. Sin. B 13, 1246\u20131261 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"77395_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).","journal-title":"Nat. Commun."},{"key":"77395_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202209216","volume":"33","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Transformable \u201ctubulin traps\u201d interfere with mitochondrial autophagy and promote the elimination of glioblastoma. Adv. Funct. Mater. 33, 2209216 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"77395_CR32","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41565-024-01785-0","volume":"19","author":"Y Zhuo","year":"2024","unstructured":"Zhuo, Y. et al. Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes. Nat. Nanotechnol. 19, 1858\u20131868 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"77395_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202408729","volume":"36","author":"P Liu","year":"2024","unstructured":"Liu, P. et al. A peptide-drug conjugate-based nanoplatform for immunometabolic activation and in situ nerve regeneration in advanced-stage Alzheimer\u2019s disease. Adv. Mater. 36, e2408729 (2024).","journal-title":"Adv. Mater."},{"key":"77395_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311043","volume":"36","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Mitochondrial localized in situ self-assembly reprogramming tumor immune and metabolic microenvironment for enhanced cancer therapy. Adv. Mater. 36, e2311043 (2024).","journal-title":"Adv. Mater."},{"key":"77395_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41529-7","volume":"14","author":"T Huang","year":"2023","unstructured":"Huang, T. et al. Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis. Nat. Commun. 14, 5781 (2023).","journal-title":"Nat. Commun."},{"key":"77395_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-025-03517-1","volume":"44","author":"H Sun","year":"2025","unstructured":"Sun, H. et al. Functional tumor-reactive CD8+ T cells in pancreatic cancer. J. Exp. Clin. Cancer Res. 44, 253 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"77395_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217617","volume":"619","author":"D Yang","year":"2025","unstructured":"Yang, D. et al. Organoid-based single cell sequencing revealed the lineage evolution during docetaxel treatment in gastric cancer. Cancer Lett. 619, 217617 (2025).","journal-title":"Cancer Lett."},{"key":"77395_CR38","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.cell.2022.06.054","volume":"185","author":"V Venkataramani","year":"2022","unstructured":"Venkataramani, V. et al. Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell 185, 2899\u20132917 (2022).","journal-title":"Cell"},{"key":"77395_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/neuonc\/noaa275","volume":"23","author":"R Xie","year":"2021","unstructured":"Xie, R. et al. Tumor cell network integration in glioma represents a stemness feature. Neuro Oncol 23, 757\u2013769 (2021).","journal-title":"Neuro Oncol"},{"key":"77395_CR40","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massagu\u00e9","year":"2023","unstructured":"Massagu\u00e9, J. & Sheppard, D. TGF-\u03b2 signaling in health and disease. Cell 186, 4007\u20134037 (2023).","journal-title":"Cell"},{"key":"77395_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41577-022-00796-z","volume":"23","author":"BG Nixon","year":"2023","unstructured":"Nixon, B. G., Gao, S., Wang, X. & Li, M. O. TGF\u03b2 control of immune responses in cancer: a holistic immuno-oncology perspective. Nat. Rev. Immunol. 23, 346\u2013362 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"77395_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1126\/science.adg1955","volume":"383","author":"P Sharma","year":"2024","unstructured":"Sharma, P. et al. Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape. Science 383, 190\u2013200 (2024).","journal-title":"Science"},{"key":"77395_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/nop009","volume":"12","author":"CA Crane","year":"2010","unstructured":"Crane, C. A. et al. TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol 12, 7\u201313 (2010).","journal-title":"Neuro Oncol"},{"key":"77395_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","volume":"41","author":"W Chen","year":"2023","unstructured":"Chen, W. TGF-\u03b2 regulation of T cells. Annu. Rev. Immunol. 41, 483\u2013512 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"77395_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-00436-9","volume":"6","author":"S Liu","year":"2021","unstructured":"Liu, S., Ren, J. & Ten Dijke, P. Targeting TGF\u03b2 signal transduction for cancer therapy. Signal Transduct. Target. Ther. 6, 8 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"77395_CR46","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-025-00832-9","volume":"25","author":"CJ Imianowski","year":"2025","unstructured":"Imianowski, C. J., Chen, Q., Workman, C. J. & Vignali, D. A. A. Regulatory T cells in the tumour microenvironment. Nat. Rev. Cancer 25, 703\u2013722 (2025).","journal-title":"Nat. Rev. Cancer"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77395-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77395-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77395-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:04:00Z","timestamp":1791821040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77395-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77395"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77395-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10672"}}